|
T.E. Rudenko, I.M. Kutyrina, M.P. Vasylieva
Natriuretic peptides: diagnostic and prognostic significance in chronic kidney disease
|
№2 / 2013
|
|
N.A. Mikhailova
Role of phosphate-binders in treatment of bone-mineral disturbances in chronic kidney disease with emphasis on phosphate homeostasis disorders in their development (review)
|
№1 / 2013
|
|
N.A. Karpacheva, E.K. Petrosian
Early diagnosis of chronic kidney disease in teenagers in ambulatory practice
|
№1 / 2013
|
|
L.Yu. Milovanova, Yu.S. Milovanov, L.V. Kozlovskaya
Use of continuous erythropoietin receptor activator in treatment of anemia in patients with predialysis chronic kidney disease
|
№1 / 2013
|
|
А.Yu. Zemchenkov, R.P. Gerasimchuk, G.А. Zemchenkov, V.Yu. Ryasnyansky
Estimation of vascular calcification in hemodialysis patients in lateral X-tay film of abdominal aorta. Review and pilot clinical trial results
|
№1 / 2013
|
|
N.A. Moukhin
Predictive medicine and clinical nephrology
|
№1 / 2013
|
|
Milovanova L.Yu., Milovanov Y.S., Dobrosmislov I.A., Moiseev S.V.
Perspectives of sevelamer in hyperphosphatemia treatment in patients with chronic kidney disease stage III–V
|
№5-6 / 2012
|
|
Rebrov A.P.,Kuklina A.L.
Renal function parameters and endothelial disfunction in patients with arterial hypertension
|
№5-6 / 2012
|
|
Burmagina A.G., Nikolaev A.Yu.
Association of prehypertension with risk factors of chronic kidney disease, arterial hypertension and atherosclerosis
|
№5-6 / 2012
|
|
Rogova I.V., Fomin V.V. , Damulin I.V. ,.Mukhin N.A.
Mild cognitive disorders in chronic kidney disease: clinical spectrum, pathogenesis, risk factors, treatment
|
№5-6 / 2012
|
|
V.V. Fomin
Role of iron sucrose in treatment of anemia in chronic kidney disease
|
№4 / 2012
|
|
E.M. Shilov
Hyperphosphatemia correction in chronic kidney disease: role of sevelamer
|
№4 / 2012
|
Русский
